Dopharma's Dexa-ject for pigs receives EU marketing authorisation

Dopharma, a family-owned Dutch manufacturer of veterinary pharmaceuticals, has obtained three new marketing authorisations in the EU, among them Dexa-ject, an inflammation treatment for pigs.

Dexa-ject 2 mg/ml is a dexamethasone injection for use in pigs, cattle, horses, dogs and cats. It is indicated for treatment of inflammatory or allergic conditions. Dexa-ject 2 mg/ml will be available in 15 EU countries (BE, DK, DE, EE, ES,FR, GB, HU, IE, IT, LT, LV, PL, RO, SE).

Related website:

Editor PigProgress

Or register to be able to comment.